Announcements

The latest company announcements from Denmark, Sweden, Norway and Finland

Ørsted signs agreement with CIP to divest its European onshore business, finalising divestment programme as planned

Ørsted, the global leader in offshore wind, has signed an agreement with Copenhagen Infrastructure Partners (CIP), through its fifth flagship fund, Copenhagen Infrastructure V (CI V), to divest its entire European onshore business. The total value of the transaction is EUR 1.44 billion (DKK 10.7 billion) with expected closing in Q2 2026, subject to regulatory approvals.

Together with the 50 % divestment of Hornsea 3 and the agreement to divest 55 % of Changhua 2, Ørsted has now signed the three cornerstone transactions that were previously announced. Ørsted has thereby finalised its divestment programme as planned and significantly strengthened its financial foundation. With the divestment of its European onshore business, Ørsted has signed transactions during 2025-2026 with proceeds totalling approx. DKK 46 billion, delivering on the company’s target of more than DKK 35 billion in proceeds during this period.

Together with the strengthening of Ørsted’s balance sheet and the finalisation of its divestment programme, the transaction also contributes to delivering on Ørsted’s strategic priority of refocusing on offshore wind in its core European markets, where a significant amount of capacity is expected to be tendered in the coming years.

Trond Westlie, Chief Financial Officer of Ørsted, says:

“Ørsted’s European onshore business has developed a very solid pipeline and project portfolio, and I’m very satisfied that we’ve found a new owner of that business in CIP, as we’ve decided to concentrate our efforts on offshore wind in our core European markets. The divestment of our European onshore platform finalises the divestment programme that we’ve laid out, and we’ve now substantially strengthened Ørsted’s financial position.”

Mads Skovgaard-Andersen, CIO and Partner in Copenhagen Infrastructure Partners, says: 

“With this significant acquisition across multiple markets and technologies, we further strengthen our presence in Europe. The combined onshore wind, solar, and BESS portfolio complements our existing project portfolio and give us the scale to further accelerate the deployment of renewable energy and strengthen Europe’s energy independence while delivering strong, risk-adjusted returns to our investors.”

Ørsted’s European onshore business is active in Ireland, the UK, Germany, and Spain and spans onshore wind, solar energy, and battery storage projects. It comprises an operational capacity of 578 MW, 248 MW under construction, and a development pipeline. Separate to its European onshore business, Ørsted continues to own and operate its onshore business in the US, which has been run as a stand-alone business, since October 2025.

For further details on the transaction structure and financial impact, please follow the following link:Annual reports and presentations | Ørsted

For further information, please contact:

Global Media RelationsMichael Korsgaard+45 99 55 95 52Globalmedia@orsted.com

Investor RelationsRasmus Keglberg Hærvig+45 99 55 90 95IR@orsted.com

About ØrstedØrsted is a global leader in developing, constructing, and operating offshore wind farms, with a core focus on Europe. Backed by more than 30 years of experience in offshore wind, Ørsted has 10.2 GW of installed offshore capacity and 8.1 GW under construction. Ørsted’s total installed renewable energy capacity spanning Europe, Asia-Pacific, and North America exceeds 18 GW across a portfolio that also includes onshore wind, solar power, energy storage, bioenergy plants, and energy trading. Widely recognised as a global sustainability leader, Ørsted is guided by its vision of a world that runs entirely on green energy. Headquartered in Denmark, Ørsted employs approximately 8,000 people. Ørsted's shares are listed on Nasdaq Copenhagen (Orsted). In 2024, the group's operating profit excluding new partnerships and cancellation fees was DKK 24.8 billion (EUR 3.3 billion). Visit orsted.com or follow us on LinkedIn and Instagram. 

About Copenhagen Infrastructure PartnersFounded in 2012, Copenhagen Infrastructure Partners P/S (CIP) today is the world’s largest dedicated fund manager within greenfield energy investments. The funds managed by CIP focus on investments in offshore and onshore wind, storage, solar PV, biomass and energy-from-waste, transmission and distribution, reserve capacity, advanced bioenergy, and Power-to-X.

CIP manages 13 funds and has to date raised approximately EUR 35 billion for investments in energy and associated infrastructure from more than 200 international institutional investors. CIP has projects in more than 30 countries and more than 2300 employees across platforms. For more information, visit www.cip.com

 

 

 

Attachments
  • Ørsted signs agreement with CIP to divest its European onshore business finalising divestment programme as planned.pdf
Danish, English

Demant A/S: Notice to annual general meeting

Notice of Annual General Meeting

To the shareholders of

Demant A/S                                                                                               3 February 2026

 

 

Notice is hereby given of the Annual General Meeting (AGM) of Demant A/S

 

Thursday, 5 March 2026 at 3:00 p.m. CET

at the company’s headquarters

Kongebakken 9, 2765 Smørum, Denmark

 

Before the AGM, coffee and cake will be served from 2:15 p.m. CET.

 

The AGM will be held as a physical meeting and will be conducted in Danish.

 

Please note that the entire AGM will be webcast on the company’s Shareholder Portal on the company’s website, https://www.demant.com/investor-relations/shareholder-portal, from 3:00 p.m. CET. The webcast will only cover podium and lectern.

 

Please see below for further information on how to attend the AGM.

 

Agenda

 

In accordance with Article 8.2 of the Articles of Association, the agenda is as follows:

 

  • The Board of Directors’ report on the company’s activities in the past year.
  •  

          The Board of Directors recommends that the general meeting take note of the report.

     

  • Presentation for approval of the audited Annual Report 2025, including the consolidated financial statements.
  •  

          The Board of Directors recommends that Annual Report 2025 be approved.

     

  • Resolution on the appropriation of profit or payment of loss according to the approved Annual Report 2025.
  •  

          The Board of Directors proposes that the profit of DKK 664 million be transferred to the company’s reserves to the effect that no dividend is paid.

     

  • Presentation of and indicative vote on Remuneration Report 2025.
  •  

  • Approval of remuneration for the Board of Directors for the current financial year.
  •  

          The Board of Directors recommends that the proposed remuneration be approved.

     

  • Election of members to the Board of Directors.
  •  

          Under Article 11.2 of the Articles of Association, Board members elected by the AGM are elected for one-year terms. At the AGM in 2026, Niels Jacobsen, Katrin Pucknat, Sisse Fjelsted Rasmussen and Kristian Villumsen stand for re-election, while Niels B. Christiansen does not stand for re-election. The Board proposes that Thomas Hofman-Bang be elected new member of the Board. As announced in company announcement dated 3 February 2026, the Board expects to elect Kristian Villumsen Chair and Niels Jacobsen Vice Chair of the Board.

     

  • Election of auditor.
  •  

          The Board of Directors proposes re-election of PwC. The Board of Directors also proposes re-election of PwC to provide an opinion on the limited assurance of sustainability reporting in the management review.

     

  • Any proposals from the Board of Directors or shareholders.
  •  

          The Board of Directors has submitted the following proposals:

     

          8a) Reduction of the company’s share capital

          8b) Authorisation to the Board of Directors to let the company acquire own shares

          8c) Approval of the company’s Remuneration Policy

          8d) Authorisation to the Board of Directors to increase the company’s share capital

          8e) Amendment of the geographical location for holding the AGM

          8f)  Authority to the chair of the AGM

     

  • Any other business.
  •  

    Elaboration on the proposals

     

    Re agenda item 4

    The Board of Directors proposes that Remuneration Report 2025 be approved. The Report is available on the company’s website, https://www.demant.com/investor-relations/annual-general-meeting.

     

    The vote is indicative pursuant to section 139b (4) of the Danish Companies Act.

     

    Remuneration Report 2024 was approved at the AGM on 6 March 2025 without comments from the shareholders.

     

    Re agenda item 5

    The Board of Directors proposes that the fixed base fee for Board members be increased by DKK 50,000 to DKK 500,000 for 2026 and that the Chair continues to receive three times the base fee and the Vice Chair twice the base fee.

     

    Furthermore, the Board of Directors proposes that the annual audit committee fee for audit committee members be increased by DKK 25,000 to DKK 125,000 for 2026 and that the chair of the audit committee continues to receive twice the annual audit committee fee.

     

    Re agenda item 6

    Niels Jacobsen, Katrin Pucknat, Sisse Fjelsted Rasmussen and Kristian Villumsen stand for re-election. The Board of Directors proposes that Thomas Hofman-Bang be elected new member of the Board of Directors. Information on each of the Board members, their managerial positions etc. follows below:

     

    Niels Jacobsen, Vice Chair (born in 1957, male, Danish). Joined the Board of Directors in 2017. Most recently re-elected in 2025 for a term of one year. He is a member of the audit, nomination and remuneration committees. He is not considered independent, as he, in his capacity as CEO of William Demant Invest A/S, is associated with William Demant Foundation (the company’s main shareholder). Other managerial positions: William Demant Invest A/S, CEO; Central Board of the Confederation of Danish Industry, board member; Federation of Industrial Employers in Denmark, chair and Thomas B. Thriges Fond (Thomas B. Thrige Foundation), chair. Related to William Demant Invest: Embla Medical hf., chair; Jeudan A/S, chair and Vision RT Ltd., chair.

     

    Niels Jacobsen holds an MSc in Economics from Aarhus University. He has substantial leadership experience from major international companies. His competencies include both business management and in-depth knowledge of financial matters, accounting, risk management and M&A. He has broad experience from the global healthcare industry.

     

    Katrin Pucknat (born in 1976, female, German). Joined the Board of Directors in 2025. She is considered independent. Other managerial positions: ResMed Inc., Chief Marketing Officer and Consumer Sleep Solutions LLC, board member.

     

    Katrin Pucknat holds a BSc in Business Marketing from University of Phoenix, USA. She has significant international general management experience from the MedTech industry as well as extensive management experience within marketing, sales, product innovation and digital business transformation.

     

    Sisse Fjelsted Rasmussen (born in 1967, female, Danish). Joined the Board of Directors in 2021. Most recently re-elected in 2025 for a term of one year. She is chair of the audit committee. She is considered independent. Other managerial positions: Conscia A/S, board member; Dades A/S, board member; Hempel Foundation, board member, (chair of Audit Commitee); Kirk Kapital A/S, board member and Schouw & Co., board member, (chair of Audit Commitee).

     

    Sisse Fjelsted Rasmussen is a state-authorised public accountant and holds an MSc in Business Administration and Auditing from Copenhagen Business School (CBS). She has extensive experience with and competencies in finance and accounting. In addition, she has extensive management and board experience from listed companies as well as competencies within value creation, change management, M&A and sustainability/ESG.

     

    Kristian Villumsen (born in 1970, male, Danish). Joined the Board of Directors in 2021. Most recently re-elected in 2025 for a term of one year. Member of the audit committee. He is considered independent. Other managerial positions: Evido ApS, chair and UV Medico A/S, vice chair.

     

    Kristian Villumsen holds an MSc in Political Science from Aarhus University and an MA in Public Policy from Harvard University, USA. He has significant international management experience from the MedTech industry as well as extensive management and board experience from listed companies within innovation, sales, strategy deployment and commercial excellence.

     

    Thomas Hofman-Bang (born in 1964, male, Danish). Proposed as new Board member. He will not be considered independent because of his seat on the board of William Demant Foundation (the company's majority shareholder). Other managerial positions: The Danish Industry Foundation, CEO; Fonden CBS Academic Housing, chair; Fonden Roskilde Festival, board member; Fabriksejer, ingeniør Valdemar Selmer Trane og hustru, Elisa Tranes Fond, chair; Tryg A/S, board member, (chair of Audit and Risk Committees); William Demant Foundation, board member and William Demant Invest A/S, board member.

     

    Thomas Hofman-Bang is a state-authorised public accountant and holds an MSc in Business Administration and Auditing from Copenhagen Business School (CBS). He has extensive competencies within strategic management and the development and implementation of growth strategies with focus on value creation. In addition, he has relevant international experience and a strong background from accounting and manufacturing companies.

     

    Re agenda item 7

    The Board proposes that PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab (PwC) is re-elected in accordance with the recommendation of the audit committee. The Board also proposes that PwC is re-elected to provide an opinion on the limited assurance of sustainability reporting in the management review. The audit committee has not been influenced by any third party and has not been subject to any agreements concluded with third parties that limit the election by the AGM of certain auditors or accounting firms.

     

    Re agenda item 8a

    The Board of Directors proposes a reduction of the company’s share capital by nominally DKK 408,274.40, divided into 2,041,372 shares of DKK 0.20, corresponding to the company’s holding of treasury shares as at 3 February 2026 less shares to cover share-based retention programmes for senior leadership and the Executive Board. The company's holding of treasury shares is, for the most part, acquired as part of the company's share buy-backs in 2025. The capital reduction is carried out in accordance with the rule on distribution to shareholders pursuant to section 188(1) (2) of the Danish Companies Act. The shares were acquired at a total price of DKK 535,646,061.00, meaning that in addition to the nominal amount of the reduction, DKK 535,237,786.60 was paid.

     

    As a result of the capital reduction, the Board of Directors proposes that Article 4.1 of the Articles of Association be amended accordingly after expiry of the time limit prescribed in section 192 (1) of the Danish Companies Act to the effect that it will then be stated in Article 4.1 that the company’s share capital is DKK 42,350,658.20.

     

    Before the capital reduction is implemented, the company’s creditors will, through the IT system of the Danish Business Authority (Erhvervsstyrelsen), be requested to file their claims within four weeks in accordance with section 192 (1) of the Danish Companies Act. Under section 193 (1) of the Danish Companies Act, the capital reduction and the resulting amendment of the company’s Articles of Association will be registered as final by the Danish Business Authority four weeks after expiry of the time limit for the filing of claims by creditors, unless the capital reduction cannot be implemented at such time under the provisions of the Danish Companies Act.

     

    Re agenda item 8b

    The Board of Directors proposes that, until the next AGM, the Board be authorised to let the company acquire own shares of a nominal value of up to 10% of the share capital. The purchase price for the shares must at the time of purchase not deviate by more than 10% from the price quoted on Nasdaq Copenhagen A/S.

     

    Re agenda item 8c

    The Board of Directors proposes that a revised Remuneration Policy be adopted.

     

    The Remuneration Policy remains materially unchanged. However, it has undergone targeted clarifications and editorial adjustments to improve readability, making its core principles and provisions more transparent and easier to navigate.

     

    It is a legal requirement that shareholders vote on the company’s remuneration policy at least once every four years.

     

    This Remuneration Policy will replace the policy approved at the AGM in March 2022. The Remuneration Reports for 2022–2024 were approved at the AGMs of the respective years without comments from shareholders.

     

    The Board’s proposal for a revised Remuneration Policy will be available on the company’s website, https://www.demant.com/investor-relations/annual-general-meeting, no later than 11 February 2026.

     

    Re agenda item 8d

     

    The Board of Directors’ existing authorisation to make capital increases set out in Article 6 of the Articles of Association expires on 1 March 2026. Therefore, the Board of Directors proposes that the following authorisations be adopted by the AGM as a replacement for the current Article 6 of the Articles of Association:

     

    “6. Authorisation to make capital increases

     

    6.1 The Board of Directors is authorised, through one or more issues, to increase the company’s share capital by issuing new shares with preferential rights of subscription for the company’s existing shareholders and with a total nominal value of up to DKK 4,200,000. The increase must be made by cash contribution to be paid in full. The authorisation will be valid up to and including 1 March 2031.

     

    6.2 The Board of Directors is also authorised, through one or more issues, to increase the company’s share capital by issuing new shares without preferential rights of subscription for the company’s existing shareholders and with a total nominal value of up to DKK 4,200,000, provided that the increase is made at market value. The increase may be made by cash contribution to be paid in full or by contribution of assets other than cash. The authorisation will be valid up to and including 1 March 2031.

     

    6.3 The Board of Directors’ authorisations under Articles 6.1 and 6.2 may, in total, be exercised by issuing new shares with an aggregate nominal value of DKK 4,200,000.

     

    6.4 In addition to the authorisations set out in Articles 6.1 to 6.3, the Board of Directors is authorised, through one or more issues, to increase the company’s share capital by issuing new shares without preferential rights of subscription for the company’s existing shareholders and with a total nominal value of up to DKK 2,100,000 when such new shares are offered to employees of the company and of any company considered an affiliate of the company by the Board of Directors. The new shares must be issued at a subscription price to be fixed by the Board of Directors, however no less than DKK 0.20 per share of DKK 0.20. The increase must be made by cash contribution to be paid in full. The authorisation will be valid up to and including 1 March 2031.

     

    6.5 With respect to capital increases under Articles 6.1, 6.2 and 6.4, the new shares must be registered in the name of the holder and registered in the company’s register of shareholders. The shares are negotiable instruments and will, in every respect, be comparable to the existing shares as regards redeemability and restricted transferability. Moreover, the Board of Directors shall lay down the specific terms for any capital increase to be implemented pursuant to the authorisations set out in Articles 6.1, 6.2 and 6.4.”

     

    The wording above shall replace the current Article 6 of the Articles of Association.

     

    Re agenda item 8e

    The Board of Directors proposes that, in the future, the AGM be held in the municipality of Egedal or in Storkøbenhavn (Greater Copenhagen). This amendment is proposed, because Region Hovedstaden will from 1 January 2027 become Region Østdanmark.

     

    The Board therefore proposes that Article 7.2 of the Articles of Association be amended:

     

    “7.2 Annual general meetings of the company must be held in the municipality of Egedal or in Storkøbenhavn (Greater Copenhagen). Subject to the legislation in force at any time, annual general meetings must be held each year before the end of April.”

     

    Re agenda item 8f

    The chair of the AGM is authorised to make any such amendments and additions to the resolutions passed by the AGM and to apply for registration of such amendments and additions with the Danish Business Authority that may be required by the Authority in connection with the registration of the amendments passed.

     

    * * * * * *

     

    Adoption of the proposed resolution under agenda item 8a (reduction of the company’s share capital), 8d (authorisation to increase the share capital) and 8e (amendment of the geographical location for holding the AGM) are subject to at least 51% of the share capital being represented at the AGM and the resolution being passed by at least two‐thirds of both the votes cast and the voting share capital represented at the AGM, cf. Article 10.3 of the Articles of Association.

     

    The other proposed resolutions on the agenda may be passed by a simple majority of votes, cf. Article 10.2 of the Articles of Association. However, the proposed voting under agenda item 4 on Remuneration Report 2025 is solely indicative.

     

    The company’s share capital is DKK 42,758,932.60, divided into shares of DKK 0.20 or multiples hereof, cf. Article 4.1 of the Articles of Association. Each share of DKK 0.20 carries one vote, cf. Article 9.1 of the Articles of Association.

     

    Participation, admission cards and voting rights

    Under Article 9.2 of the Articles of Association, shareholders who are registered as shareholders in the register of shareholders on the date of registration, 26 February 2026, or have made a request to be registered in the register of shareholders, and such request has reached the company, are entitled to attend and vote at the AGM.

     

    Shareholders entitled to attend and vote at the AGM under Article 9.2 of the Articles of Association are entitled to attend the AGM, subject to having obtained an admission card for themselves and for any adviser accompanying them to the meeting no later than 2 March 2026 at 11:59 p.m. CET.

     

    Please note that only shareholders who are registered in the register of shareholders on the date of registration and who have obtained an admission card prior to the AGM are entitled to attend.

     

    Admission cards may be obtained:

     

  • electronically through the Shareholder Portal, which can be found on the company’s website, https://www.demant.com/investor-relations/shareholder-portal,
  • by submitting the order form by post to Computershare A/S, Lottenborgvej 26 D, 1. sal, DK 2800 Kgs. Lyngby, Denmark, or by submitting a scanned copy of the order form by e-mail to gf@computershare.dk,
  • by making a written application to the company’s headquarters, Kongebakken 9, DK-2765 Smørum, Denmark (marked “Adgangskort til generalforsamling”), or
  • by appearing in person at the company’s headquarters, Kongebakken 9, DK-2765 Smørum, Denmark.
  •  

    The company will then send an electronic admission card by e-mail to the e-mail address indicated by the shareholder when registering via the Shareholder Portal. To gain access to the AGM, the admission card must be presented either electronically on a smartphone/tablet or as a hardcopy. If an error occurs with the electronic admission card, or if it is not possible to receive the admission card electronically or to print it, the admission card must be picked up upon arrival at the AGM against presentation of appropriate identification.

     

    Shareholders will receive physical voting papers upon arrival at the AGM.

     

    The company has designated Danske Bank A/S as its custodian bank through which the company’s shareholders may exercise their financial rights.

     

    * * * * * *

     

    Information on the company’s website

    No later than 11 February 2026, the following information and documents will be made available on the company’s website, https://www.demant.com/investor-relations/annual-general-meeting: 1) Notice convening the AGM, 2) the total number of shares and voting rights as at the date of the notice, 3) the documents to be submitted to the AGM, including the audited Annual Report 2025, the proposed revised Remuneration Policy and Renumeration Report 2025, 4) agenda for and complete proposals to be submitted to the AGM, and 5) postal and proxy voting forms.

     

    Written questions

    As a shareholder, you may submit written questions about the agenda and the documents to be used for the AGM. Any questions must be sent by post to the company or by e-mail to info@demant.com. Questions will be answered in writing before the AGM or orally at the AGM, unless the answer is made available on the company’s website, https://www.demant.com/investor-relations/annual-general-meeting, prior to the AGM.

     

    Submission of proxy

    If you are unable to attend the AGM, the company’s Board of Directors would be pleased to act as proxy to cast the votes attached to your shares. Proxies may be appointed electronically through the Shareholder Portal on the company’s website, https://www.demant.com/investor-relations/shareholder-portal, no later than 2 March 2026 at 11:59 p.m. CET. You may also complete, date and sign a proxy form and return it by post to Computershare A/S, Lottenborgvej 26 D, 1. sal, 2800 Kgs. Lyngby, Denmark, or return a scanned copy of the proxy form by e-mail to gf@computershare.dk, which must be in Computershare’s possession no later than 2 March 2026 at 11:59 p.m. CET. If you wish to appoint a proxy other than the Board of Directors, you may appoint a third-party proxy. Please note that you must also request an admission card for the proxy. The proxy form is available on the company’s website, https://www.demant.com/investor-relations/annual-general-meeting.

     

    Submission of postal votes

    You may also vote by post. Postal votes may be cast electronically through the Shareholder Portal on the company’s website, https://www.demant.com/investor-relations/shareholder-portal, no later than 4 March 2026 at 12:00 noon CET. You may also complete, date and sign a postal voting form, which is the same form as the proxy form, and return it by post to Computershare A/S, Lottenborgvej 26 D, 1. sal, 2800 Kgs. Lyngby, Denmark, or return a scanned copy of the voting form by e-mail to gf@computershare.dk, which must be in Computershare’s possession no later than 4 March 2026 at 12:00 noon CET. The postal voting form is available on the company’s website, https://www.demant.com/investor-relations/annual-general-meeting.

     

    Webcast

    The AGM will be webcast on the company’s Shareholder Portal on the company’s website, https://www.demant.com/investor-relations/shareholder-portal, from 3:00 p.m. Please note that it is not possible to participate actively in the AGM and ask questions or vote, if you follow the AGM via webcast. As the AGM is accessible via webcast on the company’s Shareholder Portal on the company’s website, you are not required to register or request an admission card to attend the meeting.

     

    The webcast will only cover the podium and lectern.

     

    Following the AGM, a recording will be made available on the company’s website, https://www.demant.com/investor-relations/annual-general-meeting.

     

    Personal data

    In connection with the AGM, the company collects, processes and keeps certain personal data. For further information, please refer to the company’s Privacy Notice, which is available on the company’s website, https://www.demant.com/privacy-notice.

     

    Smørum, 3 February 2026

     

    The Board of Directors

    Contacts
    • Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
    About Demant A/S

    Demant is a world-leading hearing healthcare group that offers innovative technologies, solutions and expertise to help people hear better. In every aspect, from hearing care and hearing aids to diagnostic equipment and services, Demant is active and engaged. Headquartered in Denmark, the Group employs more than 22,000 people globally and is present with solutions in 130 countries creating life-changing differences through hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.

    Attachments
    • 2026-04 Notice to annual general meeting.pdf
    Danish, English

    Demant A/S: Changes to Demant's Board of Directors

    Company announcement no 2026-03      3 February 2026

    Inside information

     

    Changes to Demant’s Board of Directors

     

    The Board intends to appoint Kristian Villumsen as new Chair of the Board

    Thomas Hofman-Bang will be proposed for election to the Board at the upcoming annual general meeting

     

    As previously announced, the current Chair of Demant’s Board of Directors, Niels B. Christiansen, has decided not to stand for re-election to the Board at the upcoming annual general meeting on 5 March 2026, after having served 17 years on the Board.

     

    The Board will propose Thomas Hofman-Bang for election. He brings international leadership experience and a strong background from accounting and manufacturing companies. He serves on the boards of William Demant Foundation and William Demant Invest A/S, which will satisfy the Foundation charter requirement for representation on Demant’s Board.

     

    After the annual general meeting, the Board intends to appoint Kristian Villumsen as new Chair. Kristian Villumsen is already a member of Demant’s Board, which he has been since 2021. He has deep insights into the healthcare industry and extensive international leadership experience from executive management and board positions.

     

    “We will ensure continuity in Board leadership by appointing Kristian Villumsen as Chair. He brings strong listed-company leadership experience and extensive insight into Demant. We also welcome Thomas Hofman-Bang, who brings relevant experience that will support Demant going forward,” says Lars Nørby Johansen, Chair of the Board of Directors of William Demant Foundation, majority shareholder of Demant.

     

    Kristian Villumsen, who is expected to become Chair of Demant’s Board of Directors, comments: “I look forward to leading Demant’s Board and supporting the company’s strategy and purpose of improving the lives of people with hearing loss.”

     

    The other members of the Board elected at the annual general meeting, Niels Jacobsen, Sisse Fjelsted Rasmussen and Katrin Pucknat, will all stand for re-election. Niels Jacobsen will continue as Vice Chair, a role he has held since 2017. The Board of William Demant Foundation supports the proposals.

     

    Kristian Villumsen currently holds the following positions:

    • Evido ApS, chair
    • UV Medico A/S, vice chair

     

    Thomas Hofman-Bang currently holds the following positions:

    • Industriens Fond, CEO
    • William Demant Foundation, board member
    • William Demant Invest A/S, board member
    • Tryg A/S, board member and chair of the Audit and Risk Committees
    • Fabriksejer, ingeniør Valdemar Selmer Trane og hustru, Elisa Tranes Fond, chair
    • Fonden CBS Academic Housing, chair
    • Foreningen Roskilde Festivalen, board member

     

    The intention to appoint Kristian Villumsen new Chair of the Board is deemed inside information pursuant to Article 17 of the Market Abuse Regulation.

     

    Further information:

    Søren Nielsen, President & CEO

    Phone +45 3917 7300

    www.demant.com

    Other contacts:

    René Schneider, CFO

    Peter Pudselykke, Head of Investor Relations

    Gustav Høegh, Investor Relations Officer

    Henrik Axel Lynge Buchter, Manager of External Communications

     

    Contacts
    • Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
    About Demant A/S

    Demant is a world-leading hearing healthcare group that offers innovative technologies, solutions and expertise to help people hear better. In every aspect, from hearing care and hearing aids to diagnostic equipment and services, Demant is active and engaged. Headquartered in Denmark, the Group employs more than 22,000 people globally and is present with solutions in 130 countries creating life-changing differences through hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.

    Attachments
    • 2026-03 Changes to Demant’s Board of Directors.pdf
    Danish, English

    Demant A/S: Annual Report 2025 and review of H2 2025

    Company announcement no 2026-02      3 February 2026

    Annual Report 2025 and review of H2 2025

    Inside information

     

     

    Revenue growth of 5% in local currencies (2% organic) in 2025 with improved performance in Q4

    EBIT before special items of DKK 3,960 million, resulting in an EBIT margin before special items of 17.2%

    Strong cash flow with CFFO of DKK 3,852 million and FCF of DKK 3,094 million

    Announcement of initiative to improve profitability, resulting in expected annual cost savings of around DKK 500 million with full effect in 2028

    Market growth assumed to be 2-4% in value in 2026, temporarily below our medium- to long-term assumptions

    Outlook for 2026: Organic growth of 3-6% and EBIT before special items of DKK 4,100-4,500 million

     

     

    “In 2025, the global hearing healthcare market grew at a slower pace than normal. With our improved performance towards the end of an eventful year, we delivered results in line with our revised financial outlook. Our Hearing Care business area demonstrated continuous strength, and both the Hearing Aids and the Diagnostics business areas saw improved performance throughout 2025. For Demant, the year was also characterised by the achievement of important milestones with the launch of Oticon Zeal and the acquisition of the large German retailer KIND. Both events support our strategy to become the leading hearing healthcare company.

     

    Despite these strategic steps and achievements, lower-than-normal hearing aid market growth and intense competition have impacted our profitability negatively. So, we will be implementing several structural changes in selected areas across the Demant Group to pave the way for improved future growth and improved profitability. This includes an intended adjustment of the size of our organisation, and while saying goodbye to valued colleagues is never easy, I am confident that the measures we are taking are necessary for Demant’s long-term success,” says Søren Nielsen, President & CEO of Demant.

     

    Financial review of FY 2025

     

    Revenue (DKK million)

     

    Growth

    Business area

    FY 2025

    FY 2024

     

    Organic

    Acquisitive

    LCY

    FX

    Reported

     

     

     

     

     

     

     

     

     

       Hearing Aids, total revenue

    12,473

     12,413

     

    2%

    1%

    2%

    -2%

    0%

       Hearing Aids, internal revenue

    -2,632

     -2,391

     

    7%

    4%

    11%

    -1%

    10%

    Hearing Aids, external revenue

    9,841

     10,022

     

    0%

    0%

    0%

    -2%

    -2%

    Hearing Care

    10,724

     9,932

     

    3%

    7%

    10%

    -2%

    8%

    Diagnostics

    2,406

     2,465

     

    1%

    0%

    1%

    -3%

    -2%

    Group

    22,971

     22,419

     

    2%

    3%

    5%

    -2%

    2%

     

    • The Group generated revenue of DKK 22,971 million. Organic growth was 2%, with acquisitive growth adding 3% and exchange rate effects contributing -2%. Total reported growth for the Group was 2% in 2025.
    • Due to a lower gross margin and despite our initiatives to lower OPEX growth, EBIT before special items amounted to DKK 3,960 million in 2025, down 10% compared to 2024 but in line with our revised outlook for the year.
    • The Group continues to be highly cash-generative and thus delivered CFFO of DKK 3,852 million for the full year. The Group’s share buy-backs amounted to DKK 582 million in 2025, before the share buy-back programme was suspended, following the announcement on 11 June 2025 to acquire KIND Group (KIND).

     

    Financial review of H2 2025

     

    Revenue (DKK million)

     

    Growth

    Business area

    Q4 2025

    Q4 2024

     

    Organic

    Acquisitive

    LCY

    FX

    Reported

     

     

     

     

     

     

     

     

     

       Hearing Aids, total revenue

    3,240

     3,179

     

    5%

    0%

    5%

    -3%

    2%

       Hearing Aids, internal revenue

    -663

     -583

     

    11%

    5%

    16%

    -2%

    14%

    Hearing Aids, external revenue

    2,577

     2,596

     

    4%

    -1%

    2%

    -3%

    -1%

    Hearing Care

    3,038

    2,698

     

    5%

    12%

    17%

    -4%

    13%

    Diagnostics

    649

    637

     

    8%

    0%

    8%

    -6%

    2%

    Group

    6,264

    5,931

     

    5%

    5%

    10%

    -4%

    6%

     

     

    Revenue (DKK million)

     

    Growth

    Business area

    H2 2025

    H2 2024

     

    Organic

    Acquisitive

    LCY

    FX

    Reported

     

     

     

     

     

     

     

     

     

       Hearing Aids, total revenue

    6,252

     6,183

     

    4%

    0%

    4%

    -3%

    1%

       Hearing Aids, internal revenue

    -1,325

     -1,183

     

    9%

    5%

    14%

    -2%

    12%

    Hearing Aids, external revenue

    4,927

     5,000

     

    3%

    -1%

    2%

    -3%

    -1%

    Hearing Care

    5,575

     5,098

     

    4%

    9%

    13%

    -4%

    9%

    Diagnostics

    1,216

     1,234

     

    3%

    0%

    3%

    -5%

    -1%

    Group

    11,718

     11,332

     

    4%

    3%

    7%

    -4%

    3%

     

    Unless otherwise indicated, the commentary below relates to H2 2025.

    • The Group generated organic growth of 4% (Q4: 5%) with performance being broad-based between business areas. Acquisitive growth added 3% (Q4: 5%), and exchange rate effects contributed -4% (Q4: -4%), resulting in total reported growth of 3% (Q4: 6%).
      • Hearing Aids saw organic growth from external customers of 3% (Q4: 4%), and we estimate that we gained market share in terms of both units and value in Q4. Growth in the Hearing Aids business improved in H2 despite a loss of market share in the US, primarily resulting from lower sales to a large retailer and a continuously softer-than-normal hearing aid market. Oticon Zeal has created excitement among hearing care professionals, with feedback so far being very positive. However, due to the phased launch in select European countries in 2025, the impact on growth in H2 was limited, as expected. If we look at our total Hearing Aids revenue, unit growth was 6%, whereas the average selling price (ASP) declined by 2% due to geography and channel mix changes.
      • Despite tough comparative figures, Hearing Care continued to deliver a solid performance in a weaker-than-normal hearing aid market with organic growth of 4% (Q4: 5%). The development was broad-based with particularly strong performances in Poland and France, where the market continued to drive strong unit growth, but as expected, the ASP development was negative due to product mix changes. In H2, growth was predominantly driven by unit sales, but it was also supported by a positive ASP development. Following closing of the acquisition of KIND on 1 December, we saw increased growth from acquisitions amounting to 9% in the period (Q4: 12%).
      • Following a soft start to the year for our Diagnostics business, we gained momentum towards the end of the year with organic growth of 3% (Q4: 8%). While we continue to see generally lower-than-normal investments in equipment in hospitals and clinics due to macroeconomic uncertainties, we saw a strong end to the year for our services and consumables business and good performance in our diagnostic instruments business. In China, we also saw an improvement in performance from a low level in H1 despite continuously limited access to participate in public markets.
    • The Group’s gross margin was 75.3%, which is a decline of 0.4 percentage points compared to H2 2024. The gross margin was positively impacted by business mix changes, which were more than offset by the ASP development due to geography and channel mix changes in Hearing Aids. A higher share of rechargeable devices sold and changes in exchange rates also contributed to the gross margin decline.
    • OPEX grew organically by 5% compared to H2 2024 and, as expected, reported OPEX was flat compared to H1 2025, reflecting continued focus on cost management. Acquisitions added an additional 5 percentage points of growth compared to H2 2024, primarily driven by smaller acquisitions completed during the year and also by KIND. Exchange rate effects were -4%.
    • EBIT before special items amounted to DKK 2,111 million, leading to an EBIT margin before special items of 18.0%, corresponding to a decline of 2.6 percentage points. EBIT before special items was negatively impacted by exchange rate effects and by lower operating leverage in Hearing Aids. The Group incurred costs recognised under special items of DKK 128 million, which partly relate to acquisition costs associated with the acquisition of KIND and partly to a non-cash adjustment of a previously recognised step-up gain in H1 2024. Reported EBIT was DKK 1,983 million.
    • The Group delivered strong cash flow with CFFO of DKK 2,339 million and FCF of DKK 1,968 million. Cash spent on acquisitions in H2 amounted to DKK 5,436 million in H2, which primarily relates to the acquisition of KIND as well as additional smaller acquisitions completed in Hearing Care.
    • Following the signed agreement to acquire KIND, the Group’s share buy-back programme was suspended on 11 June 2025. As at that date, the Group had bought back shares worth DKK 582 million in 2025.
    • Following the completion of the acquisition of KIND, the Group’s gearing multiple (NIBD/EBITDA before special items) was 3.4 at the end of 2025, which is slightly lower than our expectations. The Group will prioritise deleveraging and expects to return to its medium- to long-term gearing target of 2.0-2.5 within 18-24 months after closing of the KIND transaction.
    • Profit after tax from discontinued operations, which comprise Communications (EPOS) and Hearing Implants (our bone anchored hearing systems business, Oticon Medical), amounted to DKK -810 million, which was slightly better than expected. The loss primarily relates to various non-cash balance sheet adjustments and provisions from the signed agreements to sell Oticon Medical and EPOS.
    • To pave the way for future growth and improved profitability, we are today announcing a company-wide initiative to increase the effectiveness across our organisation. Our focus is on delivering permanent, long-term cost savings through structural changes in selected areas. We expect the measures to be implemented over the coming two years. They include utilising cost-effective locations, prioritising activities, increasing our efforts to lower production costs and tightening procurement. The measures will result in an intended adjustment to the size of the Demant organisation, which we currently expect to affect approx. 700 employees globally in 2026 of whom approx. 150 employees are located in Denmark. We expect the announced measures to lead to annual cost savings across cost of goods sold and OPEX of around DKK 500 million with full effect in 2028. Of this amount, we expect to achieve savings of DKK 250 million in 2026. As a consequence of the implemented measures, the Group will incur costs recognised under special items of around DKK 200 million in 2026 and DKK 100 million in 2027 primarily related to severance payments.

     

    Sustainability review of FY 2025
    • Through innovative solutions and personalised care provided to hearing aid users, Demant improved 12.1 million lives in 2025, representing an 11% increase compared to 2024 and putting us on track to meet our 2030 target of improving more than 16 million lives. Furthermore, we increased the number of hearing tests carried out in our hearing care clinics from 1.5 million in 2024 to 1.6 million in 2025.
    • The Group reduced its scope 1 and 2 market-based greenhouse gas (GHG) emissions by 9% compared to 2024 and 16% compared to the 2019 baseline year from which our climate targets are set. The decrease in GHG emissions is driven by an increase in our consumption of renewable electricity, which represented 53% of Demant’s total electricity consumption in 2025. We have thus reached our goal of 50% renewable electricity in 2025. Scope 3 GHG emissions declined by 7% compared to 2024 but increased by 24% compared to the 2019 baseline year.
    • Gender balance in top-level management improved to 33% female and 67% male, increasing the share of female leaders by 2 percentage points compared to 2024.
    • Demant reached an employee engagement score of 4.16 (on a scale from 1 to 5), an increase from 4.13 in 2024. We also slightly increased our inclusivity score, measuring employees’ experience of inclusion, from 4.27 in 2024 to 4.30 in 2025.
    • Increasing our excellence in business conduct, the number of highly exposed employees trained in Demant’s Code of Conduct reached 99% in 2025, which is a 23 percentage point increase compared to 2024.
    Outlook for 2026

    Our outlook for 2026 is summarised in the table below:

     

    Metric

    Outlook for 2026

    Organic growth

    3-6%

    EBIT before special items

    DKK 4,100-4,500 million

    Share buy-backs

    None

     

    The outlook is based on the following key assumptions as described below:

     

    • Due to general macroeconomic uncertainty, we expect the value growth rate in the global hearing aid market to be 2-4% in 2026, which is a conservative assumption temporarily below our medium- to long-term assumption.
    • We expect a limited impact of tariffs on the Group, but we include an impact of around DKK -25 million of tariffs in 2026 on our Diagnostics business area based on currently implemented tariffs in the US.
    • We have launched a company-wide initiative for Demant to improve profitability, which is expected to lead to cost reductions, positively impacting EBIT before special items of around DKK 250 million in 2026. The majority of the impact is expected to materialise in H2, leading to an EBIT before special items being skewed towards H2.
    • Due to exchange rate movements during 2025, we expect an impact of exchange rates on EBIT before special items of around DKK -200 million compared to 2025 with the split expected to be evenly distributed between H1 and H2.
    • We expect KIND to contribute approximately DKK 300 million to the Group’s EBIT before special items in 2026.
    • We expect to incur costs recognised as special items totalling DKK 325 million. These costs relate to previously communicated transaction and integration costs following the acquisition of KIND amounting to approximately DKK 125 million. In addition, the announced organisational and structural changes to the Group will entail one-off costs of an additional DKK 200 million primarily related to severance payments and cost related to the announced measures.

     

    For modelling purposes, we provide further assumptions for 2026 below:

     

    Metric

    Assumptions for 2026

    Acquisitive growth

    8% based on revenue from acquisitions completed as at 2 February 2026

    FX growth

    -2% based on exchange rates as at 2 February 2026, including the impact of hedging

    Special items

    DKK -325 million

    Effective tax rate

    Around 23%

     

    The financial outlook for 2026 is deemed inside information pursuant to Article 17 of the Market Abuse Regulation.

     

    Conference call details

    Demant will host a conference call on 3 February 2026 at 14:00 CET. A live webcast of the call will be available on our website www.demant.com. If you would like to attend the conference call to ask questions, please pre-register here to receive the dial-in numbers and access codes. A presentation for the call will be uploaded on our website shortly before the call.

     

    Further information:

    Søren Nielsen, President & CEO

    Phone +45 3917 7300

    www.demant.com

    Other contacts:

    René Schneider, CFO

    Peter Pudselykke, Head of Investor Relations

    Gustav Høegh, Investor Relations Officer

    Henrik Axel Lynge Buchter, Manager of External Communications

     

    Key figures and financial ratios

    (DKK million)

    H2 2025

    H2 2024

    Change

    FY 2025

    FY 2024

    Change

    Income statement

     

     

    Revenue

    11,718

    11,332

    3%

    22,971

    22,419

    2%

    Organic growth

    4%

    2%

     

    2%

    2%

     

    Gross profit

    8,824

    8,580

    3%

    17,371

    17,090

    2%

    EBITDA

    2,758

    3,066

    -10%

    5,351

    5,963

    -10%

    Operating profit before special items

    2,111

    2,336

    -10%

    3,960

    4,404

    -10%

    Special items

    -128

    -

    n.a.

    -128

    124

    n.a.

    Operating profit (EBIT)

    1,983

    2,336

    -15%

    3,832

    4,528

    -15%

    Net financial items

    -346

    -402

    -14%

    -731

    -812

    -10%

    Profit after tax – continuing operations

    1,237

    1,538

    -20%

    2,367

    2,892

    -18%

    Profit after tax – discontinued operations

    -810

    -350

    >100%

    -823

    -504

    63%

    Profit for the period

    427

    1,188

    -64%

    1,544

    2,388

    -35%

     

     

     

     

     

     

     

    Cash flow statement

     

     

     

     

     

     

    Cash flow from operating activities (CFFO)

    2,339

    2,589

    -10%

    3,852

    4,080

    -6%

    Acquisition of enterprises, participating interests and activities

    -5,436

    -471

    >100%

    -6,285

    -1,234

    >100%

    Investment in property, plant and equipment, net

    -298

    -259

    15%

    -605

    -545

    11%

    Free cash flow (FCF)

    1,968

    2,329

    -16%

    3,094

    3,486

    -11%

    Share buy-backs

    -

    -1,164

    n.a.

    -582

    -2,301

    -75%

     

     

     

     

     

     

    Balance sheet

     

     

     

     

     

     

    Equity

    9,919

    9,644

    3%

    9,919

    9,644

    3%

    Total assets

    39,074

    32,450

    20%

    39,074

    32,450

    20%

    Net interest-bearing debt (NIBD)

    18,742

    13,545

    38%

    18,742

    13,545

    38%

    Net working capital (NWC)

    3,387

    3,289

    3%

    3,387

    3,289

    3%

     

     

     

     

     

     

    Financial ratios

     

     

    Gross margin

    75.3%

    75.7%

     

    75.6%

    76.2%

     

    EBIT margin

    18.0%

    20.6%

     

    17.2%

    19.6%

     

    Effective tax rate

    24.4%

    20.5%

     

    23.7%

    22.2%

     

    Gearing multiple

    3.4

    2.3

     

    3.4

    2.3

     

     

     

     

     

     

     

     

    Share information (DKK)

     

    Earnings per share (adjusted EPS) – continuing operations

    6.40

    7.13

    10%

    11.74

    12.74

    -8%

    Earnings per share (EPS) – continuing operations

    5.86

    7.13

    -18%

    11.20

    13.31

    -16%

    Earnings per share (EPS)

    2.03

    5.52

    -63%

    7.31

    10.99

    -33%

    Share price, end of period/year, DKK

    215.20

    264.20

    -19%

    215.20

    264.20

    -19%

    We refer to Note 1.1 of Annual Report 2025 for a description of the accounting policies used for reporting key figures and financial ratios.

     

     

    Key sustainability figures and ratios

     

    FY 2025

    FY 2024

    Change

    Sustainability impacts

    Number of lives improved (million)

    12.1

    10.9

    11%

     

     

     

     

    Environment

    Scope 1 and 2 GHG emissions market-based (tonnes of CO2e)1

    26,781

    29,426

    -9%

    Scope 1 and 2 GHG emissions location-based (tonnes of CO2e)1

    35,401

    33,686

    5%

    Scope 3 GHG emissions (tonnes of CO2e)1

    194,976

    209,282

    -7%

    Share of renewable electricity

    53%

    35%

    18pp

     

     

     

     

    Social

    Gender diversity, top-level management (female/male)

    33/67%

    31/69%

    2pp

    Gender diversity, all managers (female/male)

    51/49%

    50/50%

    1%

    Inclusion score (1-5)

    4.30

    4.27

    1%

    Engagement score (1-5)

    4.16

    4.13

    1%

    Average number of full-time employees (FTE)

    22,248

    21,381

    4%

    All employees (headcount)

    26,704

    22,639

    18%

     

     

     

     

    Governance

    Code of Conduct training of highly exposed employees

    99%

    76%

    23pp

    Whistleblower reports

    126

    87

    45%

    1 2024 numbers are restated due to methodological improvement. 

     

     

     

    Contacts
    • Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
    About Demant A/S

    Demant is a world-leading hearing healthcare group that offers innovative technologies, solutions and expertise to help people hear better. In every aspect, from hearing care and hearing aids to diagnostic equipment and services, Demant is active and engaged. Headquartered in Denmark, the Group employs more than 22,000 people globally and is present with solutions in 130 countries creating life-changing differences through hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.

    Attachments
    • 2026-02 Annual Report 2025 and review of H2 2025.pdf
    Danish, English
    Digital Workforce favicon

    Digital Workforce Services Oyj: SHARE REPURCHASE 2.2.2026

    Digital Workforce Services Oyj: SHARE REPURCHASE 2.2.2026

    Helsinki Stock Exchange

    Trade date: 2.2.2026Bourse trade: BUYShare: DWFAmount: 3 610 sharesAverage price / share: 2.5136 EURTotal cost: 9 074.24 EUR

    Following shares repurchased on 2.2.2026the Company now holds 225 431 shares.

    On behalf of Digital Workforce Services OyjLago Kapital LtdMaj van Dijk     Jani Koskell

    Contact information:

    Digital Workforce Services Plc

    Jussi Vasama, CEO

    Tel. +358 50 380 9893

     

    Laura Viita, CFO

    Tel. +358 50 487 1044

    Investor relations | Digital Workforce

     

    Certified advisor 

    Aktia Alexander Corporate Finance Oy

    Tel. +358 50 520 4098

    About Digital Workforce Services Oyj

    About Digital Workforce Services Plc

    Digital Workforce Services Plc (Nasdaq First North: DWF) is a leader in business automation and technology solutions. With the Digital Workforce Outsmart platform and services—including Enterprise AI agents—organizations transform knowledge work, reduce costs, accelerate digitization, grow revenue, and improve customer experience. More than 200 large customers use our services to drive the transformation of work through automation and Agentic AI. Digital Workforce has particularly strong experience in healthcare, automating care pathways across clinical and administrative workflows to reduce burden, enhance patient safety, and return time to patient care. Following the acquisition of e18 Innovation, the company has further strengthened its position in the UK healthcare pathway automation. We focus on repeatable, outcome-based use cases, and we operate with high integrity and close customer collaboration. Founded in 2015, Digital Workforce employs more than 200 automation professionals in the US, UK, Ireland, and Northern and Central Europe. Our vision: Transforming Work – Beyond Productivity.

    https://digitalworkforce.com 

    Attachments
    • DWF_SBB_trades_20260202.xlsx
    English, Finnish

    Asuntosalkku Oyj: OMIEN OSAKKEIDEN HANKINTA 2.2.2026

    Asuntosalkku Oyj: OMIEN OSAKKEIDEN HANKINTA 2.2.2026

    Helsingin Pörssi

    Päivämäärä: 2.2.2026Pörssikauppa: OSTOOsakelaji: ASUNTOOsakemäärä: 26 osakettaKeskihinta/osake: 81.6923 EURKokonaishinta: 2 124.00 EUR

    Yhtiön hallussa olevat omat osakkeet 2.2.2026tehtyjen kauppojen jälkeen: 16 783 osaketta.

    Asuntosalkku Oyj:n puolestaLago Kapital OyMaj van Dijk     Jani Koskell

    Lisätietoja

    Asuntosalkku Oyj

    Jaakko SinnemaatoimitusjohtajaPuh. +358 41 528 0329

    jaakko.sinnemaa@asuntosalkku.fi

     

    Hyväksytty neuvonantajaAktia Alexander Corporate Finance Oy

    Puh. +358 50 520 4098

     

    Asuntosalkku Oyj

    Asuntosalkku on asuntosijoitusyhtiö, joka keskittyy omistaja-arvon luomiseen. Sijoitukset painottuvat omistusasuntotaloista valikoituihin yksittäisiin asuntoihin, joissa vuokralainen asuu omistusasujien naapurina. Pääpaino on hyvien sijaintien pienissä asunnoissa Suomen pääkaupunkiseudulla ja sen kehyskunnissa sekä Tallinnan keskusta-alueilla. Olemme vaihtoehto asuntorahastoille ja suoralle asuntosijoittamiselle. Asuntosalkku on Viron suurin markkinaehtoinen vuokranantaja ja Tallinnan vuokramarkkinoiden edelläkävijä.

    30.9.2025 Asuntosalkku omisti Suomessa 1 413 valmista asuntoa, joiden yhteenlaskettu käypä arvo oli 160,8 miljoonaa euroa, sekä Tallinnassa 660 valmista asuntoa, joiden yhteenlaskettu käypä arvo oli 103,1 miljoonaa euroa. Asuntosalkun taloudellinen vuokrausaste 30.9.2025 oli 97,9 prosenttia.

    Asuntosalkun perustajat ovat Jaakko Sinnemaa ja Timo Metsola. He ovat yhtiöidensä kautta myös Asuntosalkun keskeisiä omistajia.

     

    www.asuntosalkku.fi

    Liitteet
    • Lataa tiedote pdf-muodossa.pdf
    • DEV-ASUNTO_SBB_trades_20260202.xlsx
    Finnish

    US federal court grants preliminary injunction allowing Sunrise Wind construction to resume

    Today, the U.S. District Court for the District of Columbia granted the preliminary injunction sought by Sunrise Wind LLC (‘Sunrise Wind’) regarding the 22 December 2025 suspension order issued by the Director of the Department of the Interior’s Bureau of Ocean Energy Management (‘BOEM’). The court’s action will allow the Sunrise Wind Project (the ‘Project’) to restart impacted activities immediately while the underlying lawsuit challenging the 22 December 2025 BOEM Director’s Order progresses. Sunrise Wind will determine how it may be possible to work with the US Administration to achieve an expeditious and durable resolution. 

    The Project will resume construction work as soon as possible, with safety as the top priority, to deliver affordable, reliable power to the State of New York. 

    Sunrise Wind is a wholly owned subsidiary of Ørsted A/S.  

    For further information, please contact:

    Global Media Relations+45 99 55 95 52Globalmedia@orsted.com 

    Investor RelationsValdemar Hoegh Andersen+45 99 55 56 71IR@orsted.com

    About ØrstedØrsted is a global leader in developing, constructing, and operating offshore wind farms, with a core focus on Europe. Backed by more than 30 years of experience in offshore wind, Ørsted has 10.2 GW of installed offshore capacity and 8.1 GW under construction. Ørsted’s total installed renewable energy capacity spanning Europe, Asia Pacific, and North America exceeds 18 GW across a portfolio that also includes onshore wind, solar power, energy storage, bioenergy plants, and energy trading. Widely recognized as a global sustainability leader, Ørsted is guided by its vision of a world that runs entirely on green energy. Headquartered in Denmark, Ørsted employs approximately 8,000 people. Ørsted's shares are listed on Nasdaq Copenhagen (Orsted). In 2024, the group's operating profit excluding new partnerships and cancellation fees 

    Attachments
    • US federal court grants preliminary injunction allowing Sunrise Wind construction to resume.pdf
    Danish, English

    Topsoe A/S – Upgrade of the guidance for the EBIT before special items margin for 2025

    Company announcement No. 02/2026

    Topsoe upgrades its guidance for the EBIT before special items margin for 2025 from 6.5 – 8.5% (as published 27 August 2025) to 8.9%, subject to the finalization of statutory audit.

    The change in the guidance for the EBIT before special items margin is primarily related to the win of an arbitration case in December.

    Topsoe’s annual report for 2025 will be published as planned on 4 March 2026, at which time further details regarding the financial results will be provided.

     

    For further information, please contact:

    Group Finance & Investor RelationsAnders Hindum, Vice PresidentPhone: +45 22 75 46 43Mail: anhi@topsoe.com

    About Topsoe

    Topsoe is a leading global provider of advanced technology and solutions for the energy transition.

    Built on decades of scientific research and innovation, we are working with customers and partners to drive energy resiliency and to achieve their sustainability goals.

    We offer world-leading solutions for transforming renewable resources into fuels and chemicals, and we provide technologies needed to produce low-carbon and conventional fuels and chemicals as well as ensuring clean air.

    We were founded in 1940 and are headquartered in Denmark, with over 2,800 employees serving customers all around the globe. To learn more, visit  www.topsoe.com. 

    Attachments
    • Download announcement as PDF.pdf
    English

    Vend Marketplaces ASA: Repurchase of own shares

    Please see below information about transactions made under the buyback programme announced on 12 November 2025.

    Date on which the repurchase programme was announced: 12 November 2025.

    The duration of the repurchase programme: The buyback programme is planned to be finalised within 23 June 2026.

    Size of the repurchase programme: The share buyback programme will cover purchases of up to a maximum value of NOK 2 billion.

    For the period 26 until 30 January 2026, Vend has purchased a total of 460,917 own shares at an average price of NOK 275.7171 per share.

    Overview of transactions:

    Date

    Trading Venue

    Aggregated daily volume (number of shares)

    Weighted average share price per day (NOK)

    Total daily transaction value (NOK)

    26 Jan 2026

    Oslo Børs

    39,855

    285.4460

    11,376,450

    CBOE

    24,482

    285.6095

    6,992,292

    Aquis

    7,463

    285.2818

    2,129,058

    Turquoise

    9,117

    285.3576

    2,601,605

    27 Jan 2026

    Oslo Børs

    48,019

    281.8293

    13,533,161

    CBOE

    30,165

    281.8383

    8,501,652

    Aquis

    7,269

    283.0822

    2,057,725

    Turquoise

    9,547

    282.2465

    2,694,607

    28 Jan 2026

    Oslo Børs

    47,119

    274.8558

    12,950,930

    CBOE

    31,178

    274.8790

    8,570,177

    Aquis

    7,106

    274.3542

    1,949,561

    Turquoise

    9,597

    275.0058

    2,639,231

    29 Jan 2026

    Oslo Børs

    46,944

    268.7430

    12,615,871

    CBOE

    31,826

    268.7239

    8,552,407

    Aquis

    7,014

    269.9783

    1,893,628

    Turquoise

    9,216

    269.4240

    2,483,012

    30 Jan 2026

    Oslo Børs

    55,730

    268.7218

    14,975,866

    CBOE

    27,983

    269.0053

    7,527,575

    Aquis

    5,885

    269.4515

    1,585,722

    Turquoise

    5,402

    268.8195

    1,452,163

    Total for period

    Oslo Børs

    237,667

    275.3949

    65,452,279

    CBOE

    145,634

    275.6506

    40,144,104

    Aquis

    34,737

    276.8142

    9,615,693

    Turquoise

    42,879

    276.8399

    11,870,618

    Total

    460,917

    275.7171

    127,082,694

    Previously disclosed

    Oslo Børs

    1,260,956

    279.3225

    352,213,444

    CBOE

    811,536

    278.6669

    226,148,225

    Aquis

    294,427

    279.5034

    82,293,359

    Turquoise

    327,338

    279.4709

    91,481,452

    Total

    2,694,257

    279.1629

    752,136,480

    Total for programme

    Oslo Børs

    1,498,623

    278.6997

    417,665,724

    CBOE

    957,170

    278.2080

    266,292,329

    Aquis

    329,164

    279.2196

    91,909,052

    Turquoise

    370,217

    279.1662

    103,352,070

    Total

    3,155,174

    278.6595

    879,219,174

    Following the transactions above, Vend Marketplaces ASA (“Vend”) has bought back a total of 3,155,174 shares with a transaction value of approx. NOK 879,219,174 under the buyback programme.

    The issuer's holding of own shares:

    Following the completion of the above transactions, Vend owns a total of 3,434,126 own shares, corresponding to 1.57% of total issued shares in Vend.

    Appendix:

    A detailed overview of all transactions made under the buyback programme that have been carried out during the above-mentioned time period is attached to this notice and available at www.newsweb.no.

    Oslo, 2 February 2026

    Vend Marketplaces ASA

    Disclosure regulation

    This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

    Contacts
    • Jann-Boje Meinecke, SVP FP&A and Investor Relations, Vend Marketplaces ASA, +47 941 00 835, ir@vend.com
    Attachments
    • Download announcement as PDF.pdf
    • 20260202 VEND Trade Details.pdf
    English

    Share-based incentive program 2025/26

    Nørresundby, 2 February 2026

    Announcement no. 10/2026

     

    The Board of Directors of RTX A/S has decided to continue the share-based incentive program in accordance with the current remuneration policy adopted at the Annual General Meeting on 29 January 2026. Therefore, RTX will launch a share-based incentive program for 2025/26 comprising a long-term share-based bonus in the form of Restricted Share Units (“RSU”) as defined in the remuneration policy and as further described below.

    The remuneration policy of RTX is available at www.rtx.dk in the “Investors” section.

     

    Restricted Share Units

    As in previous years, the long-term share-based bonus in the form of RSUs will be earned and matured over a three-year period based on the continued employment of each participant and based on a minimum floor level of earnings is achieved in the three-year period from the award. Subject to vesting, each RSU provides the participant with the right to receive one share in RTX A/S of nominally DKK 5.

     

    Participants and Purpose

    The Executive Board and Group Executive Management. In total, the program for 2025/26 includes 8 participants. The purpose of the program is to create shared interests between the participants in the program and RTX and its shareholders as well as to create incentives for the retention of the participants at RTX. The targets set in the program are set so as to emphasize incentives related to retention.

    Number of Restricted Share Units

    If all pre-defined targets are met or exceeded, a total number of 36,895 shares will be granted with a total present value / fair value of DKK 4.0 million as calculated based on an adjusted Black-Scholes model reflecting the specific terms and conditions of the program and the share price at the time of RTX’s Annual General Meeting on 29 January 2026.

     

    The actual number of RSUs distributed may range from

    0 to 100 percent of the total number above and is determined by RTX’s performance in the financial years 2025/26, 2026/27 and 2027/28 being above a certain minimum threshold and by the continued employment of the participants.

    Timing

    The RSUs will at the earliest vest and be granted as shares after the Annual General Meeting in January 2029.

    Targets/Performance Indicators

    The vesting of RSUs depends on the fulfillment of a defined minimum target for EBITDA in the three-year period from the award (financial years 2025/26, 2026/27 and 2027/28) and it is further dependent on the conduct of RTX’s business in compliance with the principles of the UN Global Compact as adopted by RTX.

    Conditions

    The RSUs are governed by the specific terms and conditions of the program in accordance with the remuneration policy of RTX and subject to mandatory law. If a participant chooses to leave RTX before the time of vesting, the participant’s right to receive the shares will generally lapse. No payments for the granted shares are made by the participants.

    Adjustments to the Program

    The number of shares available for grant may be adjusted in the event of relevant changes in the capital structure of RTX. Further the program is subject to a usual clawback provision.

     

    The total number of RSUs granted is covered by the Company’s current holding of treasury shares.

     

    Questions and further information:

    CFO Mille Tram Lux, tel: +45 96 32 23 00

    Contacts
    • Henrik Mørck Mogensen, CEO, RTX A/S, +45 96322300, hmm@rtx.dk
    • Mille Tram Lux, CFO, +45 96322300, mtl@rtx.dk
    About RTX

    RTX innovates, designs, and manufactures wireless communication solutions within Enterprise, Healthcare, and ProAudio. Working in close partnership with our customers, we offer customized, 'turn-key', end-to-end solutions with full product lifecycle management designed to make a difference in the market. We are a global company employing 300+ people at our locations in Denmark, Hong Kong, Romania and USA.

    Attachments
    • Download announcement as PDF.pdf
    • RTX CA No 10-2026 - 02.02.26 - Share-based Incentive Program 2025_26.pdf
    Danish, English

    Transactions carried out under the buy-back program

    On June 2nd Nekkar announced its decision to renew the share buy-back program. The share buy-back program is executed in accordance with the authorization granted to the Board of Directors by the Annual General Meeting of Nekkar ASA held on May 28, 2025. The program will be used for corporate purposes in accordance with the above-mentioned authorization. The share buy-back program covers purchase of up to 10,742,711 shares, and the maximum amount of the program is NOK 100 million. The renewed program commenced on June 2nd and is planned finalized within May 30th, 2026 at the latest.  

    The share buy-back program is managed by an independent third party, which makes its trading decisions regarding the timing of the share repurchases independently of, without influence by, and without access to sensitive information concerning Nekkar.

    During week 05 of 2026, Nekkar purchased 75000 own shares at an average price of NOK 12,6261 per share. Including shares acquired under previous buy-back programs and adjusted for shares used in employee programs and acquisitions, Nekkar now holds a total of 9 588 370 own shares, corresponding to 8.925 percent of the shares in the company.

    Below is a more detailed overview of the transactions carried out under the renewed buy-back program.

    Date Number of shares Average price (NOK) Total transaction value (NOK) 26/01/2026 15,000 12.8555 192,832.40 27/01/2026 15,000 12.90000 193,500.00 28/01/2026 15,000 12.6750 190,125.00 29/01/2026 15,000 12.5000 187,500.00 30/01/2026 15,000 12.2000 183,000.00 Previously announced buy-backs under the program 4,087,019.00  10.9254 44,652,226.70  Total buy-backs made under the program 4,162,019.00  10.9560  45,599,184.10 

    Appendix: For a comprehensive overview of all transactions conducted under the buy-back program during the beforementioned time frame, we have attached an appendix to this report

    Disclosure regulation

    This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.

    Contacts
    • Marianne Voreland Ottosen, CFO, Nekkar ASA, +4740202593, mvo@nekkar.com
    About Nekkar ASA

    Nekkar (OSE: NKR) is an industrial long-term owner of ocean-based technology companies. The company invests in and develops technology businesses within sustainable oceans, robotics and intelligent logistics, and digital solutions. With a 50-year industrial heritage from Syncrolift, Nekkar applies an active buy-to-own strategy to build long-term value. The group supports empowered operating companies with a strong balance sheet and reinvests strategically to ensure profitability and sustainable growth. As a publicly listed company, Nekkar has a proven track record of shareholder value creation through disciplined M&A, financial management, and capital allocation.

    Attachments
    • NKR buy back 02022026.pdf
    English

    Transactions under the current share buyback programme

    On 3 June 2024, Per Aarsleff Holding A/S launched a share buyback programme, as described in company announcement no. 12 of 28 May 2024. On 28 February 2025, the programme was increased and extended cf. company announcement no. 30, and until 1 March 2026, Per Aarsleff Holding A/S will buy back own B shares up to a maximum value of DKK 300 million and with a maximum of 1,100,000 B shares. 

    The share buyback programme will be implemented in accordance with Regulation (EU) no. 596/2014 of 16 April 2014 of the European Parliament and Council and Commission Delegated Regulation (EU) no. 2016/1052, also referred to as the Safe Harbour rules.

    Trading day

    Number of shares bought back

    Average purchase price

    Amount, DKK

    390: 26 January 2026

                                  600

    895.44

    537,265.02

    391: 27 January 2026

                                  600

    900.00

    540,000.00

    392: 28 January 2026

                                  600

    886.50

    531,900.00

    393: 29 January 2026

                                  600

    885.00

    531,000.00

    394: 30 January 2026

                                  600

    898.00

    538,800.00

    Accumulated trading for days 390-394

            3,000

              892.99

    2,678,965.02

    Total accumulated

                          575,658

    501.77

    288,847,297.29

    See the enclosure for information about the individual transactions made under the share buyback programme.

    Contacts
    • Jesper Kristian Jacobsen, Administrerende koncerndirektør / Group CEO, +45 8744 2222
    About Per Aarsleff Holding A/S

    The Aarsleff Group is a building construction and civil engineering group with an international scope and a market leading position in Denmark. The Group comprises a portfolio of independent, competitive companies each with their own specialist expertise. 

    Attachments
    • Aktietilbagekøb uge 05 2026_UK.pdf
    • Share repurchase specification week 05 2026.pdf
    Danish, English

    Share buy-back programme

    Nørresundby, 2 February 2026

    Announcement no. 09/2026

      

    The Board of Directors of RTX has, cf. company announcement no. 16/2025 dated 28 August 2025, resolved to initiate a share buy-back programme in accordance with the provisions of Article 5 Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (MAR) and the Commission’s delegated Regulation (EU) 2016/1052, also referred to as the "Safe Harbor" regulation.

     

    Under the programme RTX will buy back shares for an amount up to DKK 20 million in the period from 1 September 2025 to 1 September 2026.

     

    The following transactions have been made under the programme in the period below:

    Number of Shares

    Average Purchase Price

    Transaction value in DKK

    RTX shares prior to initiation of the programme

    489,362

     

     

    Accumulated share in the programme, latest announcement

    96,295

     

    9,764,848

    Monday, January 26

    600

    116.64

    69,984

    Tuesday, January 27

    700

    116.65

    81,655

    Wednesday, January 28

    700

    117.51

    82,257

    Thursday, January 29

    600

    118.08

    70,848

    Friday, January 30

    600

    114.90

    68,940

    Accumulated under the programme

    99,495

    101.90

    10,138,532

    RTX total shares

    8,467,838

    RTX Treasuty shares

    588,857

    6.95%

    of share capital

    In accordance with the Regulation (EU) No. 596/2014, transactions related to the share buy-back programme are presented in detailed form in the appendix attached to this company announcement.

     

    Enquiries and further information:

    CEO Henrik Mørck Mogensen, tel +45 96 32 23 00

    Contacts
    • Henrik Mørck Mogensen, CEO, RTX A/S, +45 96322300, hmm@rtx.dk
    • Mille Tram Lux, CFO, +45 96322300, mtl@rtx.dk
    About RTX

    RTX innovates, designs, and manufactures wireless communication solutions within Enterprise, Healthcare, and ProAudio. Working in close partnership with our customers, we offer customized, 'turn-key', end-to-end solutions with full product lifecycle management designed to make a difference in the market. We are a global company employing 300+ people at our locations in Denmark, Hong Kong, Romania and USA.

    Attachments
    • Download announcement as PDF.pdf
    • RTX CA No 09-2026 - 02.02.26 - Share buy-back programme.pdf
    Danish, English

    Leading Baltic-based grocery retailer orders EUR 1 million of self-checkouts from StrongPoint

    (Oslo, 2 February 2026) One of the largest grocery retailers in the Baltics has placed an order with StrongPoint to supply and install additional self-checkouts in its stores.

    The order is valued at approximately EUR 1 million. The agreement does not include implementation and future technical support. Delivery and installation are planned for Q3 2026. This comes on the back of previous orders from the same grocery retailer for self-checkouts from StrongPoint.

    “We are proud to continue supporting this long-standing customer with self-checkout solutions. This continued partnership is a testament to the consistently strong customer intimacy our Baltic team has built with this key grocery retail customer,” said Jacob Tveraabak, CEO of StrongPoint.

    “We appreciate that this customer has continued to work with StrongPoint over many years on this business-critical in-store technology. We are looking forward to starting the installation process and supporting them on their journey in providing better and faster self-checkout experiences,” said Rimantas Mažulis, SVP of StrongPoint Baltics.

    Disclosure regulation

    This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

    Contacts
    • Marius Drefvelin, CFO StrongPoint ASA, +47 958 95 690, marius.drefvelin@strongpoint.com
    About StrongPoint

    StrongPoint is a grocery retail technology company that provides solutions to make shops smarter, shopping experiences better, and online grocery shopping more efficient. With approximately 500 employees in Norway, Sweden, the Baltics, Finland, Spain, the UK and Ireland, and together with a wide partner network, StrongPoint supports grocery and retail businesses in more than 20 countries. 

    StrongPoint provides end-to-end e-commerce solutions, including in-store order picking, automated fulfillment (with AutoStore), click & collect temperature-controlled grocery lockers, and in-store and drive-thru grocery pickup solutions. The company also delivers a range of in-store technologies, such as electronic shelf labels, AI-powered self-checkouts, and cash management and payment solutions. StrongPoint is headquartered in Norway and is listed on the Oslo Stock Exchange with a revenue of approximately NOK 1.3 billion [ticker: STRO]. 

    Attachments
    • Download announcement as PDF.pdf
    English

    TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

    On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations.                                                                                            

    During the program, Ambu will repurchase shares for a total amount of up to DKK 150m from 10 December 2025 until no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR.

    The following transactions have been made under the program from 26 January to 30 January 2026:

     

     

    Number of shares

    Average purchase price, DKK

    Transaction value, DKK

    Accumulated under the program after last announcement

    1,034,445

    86.5836

     89,565,949

    2026.01.26

    2,564

    86.3954

     221,518

    2026.01.27

    100,000

    86.1475

     8,614,750

    2026.01.28

    190,000

    85.4863

     16,242,397

    2026.01.29

    146,111

    84.9017

     12,405,072

    2026.01.30

    2,150

    84.6820

     182,066

    Accumulated under the program

    1,475,270

    86.2430

    127,231,753

    After the above mentioned transactions DKK 22,768,247 remains to be repurchased. Ambu now owns 3,924,394 treasury shares, corresponding to 1.5% of the share capital.

    Contacts
    • Anders Hjort, Head of Investor Relations, +45 2892 8881, anhj@ambu.com
    • Tine Bjørn Schmidt, Director of Corporate Communications, +45 2264 0697, tisc@ambu.com
    About Ambu A/S

    Ever since 1937, Ambu has surpassed expectations with groundbreaking solutions that improve patient care. Millions of patients, clinicians, and health systems worldwide rely on our endoscopy, anesthesia, and patient monitoring solutions for efficiency, safety, and performance. Our ownership of every stage of the product life cycle enables us to work closely with healthcare professionals, maintain a reliable product supply, and uphold full transparency. At our headquarters in Copenhagen, Denmark, and around the world in Europe, North America, and the Asia Pacific, 5,200+ Ambu team members are committed to delivering above and beyond.

    Attachments
    • Download announcement as PDF.pdf
    English

    Andfjord Salmon – Grant of options to primary insiders

    The board of Andfjord Salmon Group AS ("Andfjord Salmon" or the "Company") has granted options to the following primary insiders of the Company:

    • Martin Rasmussen, CEO: 250,000 options
    • Bjarne Martinsen, CFO: 150,000 options
    • Christian Torgersen, COO: 80,000 options
    • Trond Rismo, CCO: 80,000 options

    Each option entitles the holder to subscribe for one new share in the Company at a price of NOK 28.80 per share (based on a ten-day volume-weighted average price (VWAP)) and will vest over a three-year period, with one third vesting after 12 months, an additional third after 24 months, and the remaining third after 36 months.

    Please refer to the attached document for further details.

    Disclosure regulation

    This information is subject to the disclosure requirements pursuant to article 19 of the regulation EU 596/2014 (the EU Market Abuse Regulation) and section 5 -12 of the Norwegian Securities Trading Act.

    Contacts
    • Investors: Bjarne Martinsen, CFO, Andfjord Salmon Group AS, +47 975 08 345, bjarne.martinsen@andfjord.no
    • Media: Martin Rasmussen, CEO, Andfjord Salmon Group AS, +47 975 08 665, martin@andfjord.no
    About Andfjord Salmon

    Located at Andøya on the Arctic Archipelago of Vesterålen, Norway, Andfjord Salmon is developing the world's most sustainable and fish-friendly aquaculture facility of its kind. Through a proprietary flow-through system, Andfjord Salmon combines the best from ocean and land-based salmon farming. In its first production cycle, the company achieved an industry-leading survival rate of 97.5 percent, feed conversion ratio of 1.05, superior share of 91.1 percent, and required 1 kWh to produce one kilo of salmon.

    For more information, see www.andfjordsalmon.com - http://www.andfjordsalmon.com

    Attachments
    • ANDF - PDMR Notification Form Options Grant 260130.pdf
    English